baber/WOPTO huggingface dataset:
Patent ES-2079343-T1 (ES)
Inventor: VANDERSCHAEGHE CHRISTIAN
IPC: G05D3/10
Filed: 1995-02-20
Abstract: The drive circuit has mechanically operated switches (ID,IM) at certain points on the travel of the motor for detecting displacement. An initialisation is set off by one switch causing the motor (E1,E2) to operate at a reduced torque for a given time (TP, x, C4). Alternatively, the initialisation uses a reduced torque supply and, in addition, a rotation blocking detector (RB) which cuts the power to the motor. The motor is an a synchronous single phase motor with a phase difference capacitor and the blocking detector is a relay (X') powered via a rectifying circuit by the voltage across the capacitor (C3). A brake operates on default of the current. There is also an instant power cut-off to the motor and a timed power cut-off to the brake (F).
Patent ES-2120398-T1 (ES)
Inventor: SIEDLER UWE
IPC: A61F2/44
Filed: 1998-02-19
Abstract: The prosthesis or plate is implanted in a patient's spinal column between two vertebrae. It has two plate elements (14,18) which may fit together two anchoring surfaces (10,12) which have a scalloped surface with sharp pyramid-shaped points separated by arcs of circles or concave spherical surfaces. There are cutouts (24,26,28) in the sides and upper surfaces of each plate, which allow the bone to grow into the plate. The end surfaces of each rectangular plate may be flat.
Patent ES-2143448-T1 (ES)
Title: Dispositivo para separar capas flotantes en un tanque de liquido.
Inventor: HEYEK KURT
IPC: B01D21/24
Filed: 1998-01-23
Abstract: LA INVENCION SE REFIERE A UN DISPOSITIVO PARA SEPARAR CAPAS FLOTANTES, POR EJEMPLO, LODO, ESPUMA U OTRAS, DE UN LIQUIDO QUE SE ENCUENTRA EN UN RECIPIENTE PARA LIQUIDOS, POR EJEMPLO, UN TANQUE DE ACLARADO, Y QUE ESTA DEBAJO DE LA CAPA FLOTANTE, SOPORTANDOLA, CON UN DISPOSITIVO GIRATORIO DE TRANSPORTE QUE LLEVA LA CAPA FLOTANTE A UNA ZONA DE DESCARGA DEL TRANSPORTADOR. EL DISPOSITIVO TRANSPORTADOR ESTA FORMADO POR AL MENOS UNA UNIDAD DE DESPLAZAMIENTO (3) IMPULSADA POR UN DISPOSITIVO DE ACCIONAMIENTO (9), Y QUE ACCIONA LA CAPA FLOTANTE DE LA SUPERFICIE DEL LIQUIDO HASTA LA ZONA DE DESCARGA DEL TRANSPORTADOR (7). LA UNIDAD DE DESPLAZAMIENTO PUEDE ESTAR DOTADA, POR EJEMPLO, DE UNA SUPERFICIE DE TORNILLO (4) QUE SE DESPLAZA A LO LARGO DEL EJE LONGITUDINAL. LA UNIDAD DE DESPLAZAMIENTO PUEDE LLEVAR, POR EJEMPLO, UNA SUPERFICIE DE TORNILLO (4) QUE SE DESPLAZA A LO LARGO DEL EJE LONGITUDINAL.
Patent CY-1107036-T1 (CY)
Inventor: CIUFOLINI MARCO
IPC: A61P25/00
Filed: 2007-11-27
Abstract: Novel compounds selected from 2-(3-aminoaryl)amino-4-aryl-thiazoles of formula (I) that selectively modulate, regulate, and/or inhibit signal transductions mediated by certain native and/or mutant tyrosine kinases implicated in a variety of human and animal diseases such as cell proliferative metabolic, allergic and degenerative disorders. More particularly, these compounds are potent and selective c-kit inhibitors.
Patent CY-1107415-T1 (CY)
Inventor: SCHUTZE FRANCOIS
IPC: A61P1/04
Filed: 2008-04-21
Abstract: Composition comprises at least one histamine H2 receptor antagonist and tenatoprazole or its potassium, magnesium, sodium or calcium salts.
Patent CY-1112137-T1 (CY)
Inventor: SCHICK HANS
IPC: C07D498/10
Filed: 2011-12-05
Abstract: Substituted spiro-compounds (I) and their pure stereoisomers, preferably enantiomer or diastereomer, racemates or mixture of stereoisomers, preferably enantiomer and/or diastereomer, salts and solvates, are new. Substituted spiro-compounds of formula (I) and their pure stereoisomers, preferably enantiomer or diastereomer, racemates or mixture of stereoisomers, preferably enantiomer and/or diastereomer, salts and solvates, are new. m : 0-4; n : 0-2; R 1>e.g. aliphatic compound, cycloaliphatic group or (hetero)aryl (all optionally substitued); either R 2>e.g. aliphatic compound, cycloaliphatic group or (hetero)aryl (all optionally substitued); and R 3>e.g. H or optionally substituted aliphatic compound; or NR 2>R 3>e.g. optionally substituted cycloaliphatic group; R 4>e.g. halo, NO 2 or CN; R 5>e.g. H, halo, NO 2, CN or amino; R 6>, R 8>e.g. optionally substituted (cyclo)aliphatic compound; R 7>, R 9>e.g. H, optionally substituted aliphatic compound or optionally substituted cycloaliphatic group; and R 10>-R 25>e.g. aliphatic compound, cycloaliphatic group or (hetero)aryl (all optionally substitued). Full Definitions are given in the DEFINITIONS (Full Definitions) Field. An independent claim is included for the preparation of (I). [Image] ACTIVITY : Analgesic; Antimigraine; Antidepressant; Neuroprotective; Nootropic; Antiparkinsonian; Anticonvulsant; Respiratory-Gen.; Antiasthmatic; Antiinflammatory; Antitussive; Uropathic; Gastrointestinal-Gen.; Cerebroprotective; Vasotropic; Dermatological; Antidiarrheic; Antipruritic; Eating-Disorders-Gen.; Immunomodulator; Anabolic; Anorectic; Antiaddictive; Cardiovascular-Gen.; Muscular-Gen.; Tranquilizer; Hypotensive. MECHANISM OF ACTION : Vanilloid receptor-1 agonist.
Patent CY-1112853-T1 (CY)
Title: Ενδιαμεση ενωση 4-(ακετυλαμινο)-3-[(4-χλωροφαινυλ)θειο]-2-μεθυλ-1η-ινδολη-1-οξικο οξυ αιθυλεστερα
Inventor: MOHAMMED RUKHSANA TASNEEM
IPC: C07D209/30
Filed: 2012-05-29
Abstract: Η παρούσα εφεύρεση αναφέρεται στην ένωση 4-(ακετυλαμινο)-3-[(4-χλωροφαινυλ)θειο]-2-μεθυλ-1H- ινδολη-οξικό οξύ αιθυλεστέρα ως ενδιάμεση για την παρασκευή 4-(ακετυλαμινο)-3-[(4-χλωροφαινυλ)θειο]-2-μεθυλ-1H-ινδολη-οξικού οξέος, το οποίο είναι ένας ρυθμιστής της δράσης του υποδοχέα CRTh2, χρήσιμος για την θεραπευτική αντιμετώπιση αναπνευστικών διαταραχών.
Patent CY-1116328-T1 (CY)
Title: Παραγωγα 4 - αμινοπυριμιδινης και η χρηση τους ως ανταγωνιστων α2α υποδοχεων αδενοσινης
Inventor: CAMACHO GÓMEZ JUAN ALBERTO
IPC: A61K31/506
Filed: 2015-04-16
Abstract: Νέα παράγωγα 4-αμινο-πυριμιδίνης ως ισχυροί ανταγωνιστές του A2a υποδοχέα αδενοσίνης του τύπου (I). Η εφεύρεση παρέχει επίσης μέθοδο για την παρασκευή τέτοιων ενώσεων, φαρμακευτικών συνθέσεων που περιέχουν αποτελεσματική ποσότητα αυτών των ενώσεων και τη χρήση τέτοιων ενώσεων στην κατασκευή φαρμάκου για τη θεραπευτική αγωγή παθήσεων που μπορούν να βελτιωθούν μέσω ανταγωνισμού του A2a υποδοχέα αδενοσίνης.
Patent CY-1117077-T1 (CY)
Title: Μεθοδοι παρασκευης χλωριομενων υδρογονανθρακων
Inventor: WILSON RICHARD L
IPC: C07C17/38
Filed: 2015-12-22
Abstract: Μέθοδοι για την βιομηχανική παρασκευή του 1,1,1,2.3-πενταχλωροπροπανίου από 1,1,1,3-τετραχλωροπροπάνιο και χλώριο αποκαλύπτονται. Βελτιωμένες μέθοδοι παρέχονται για την βιομηχανική παρασκευή του 1,1,2,3-τετραχλωροπροπενίου από 1,1,1,2,3-πενταχλωροπροπάνιο. Μέθοδοι αποκαλύπτονται επίσης και για την βιομηχανική παρασκευή του 1,1,2,3-τετραχλωροπροπενίου από 1,1,1,3-τετραχλωροπροπάνιο και χλώριο και για την βιομηχανική παρασκευή του 1,1,2,3-τετραχλωροπροπενίου από τετραχλωράνθρακα, αιθυλένιο, και χλώριο.
Patent CY-1117743-T1 (CY)
Title: Διυποκατεστημενα οκταϋδροπυρρολο [3,4-c]πυρρολια ως ρυθμιστες υποδοχεα ορεξινης
Inventor: CHAI WENYING
IPC: A61K31/407
Filed: 2016-07-05
Abstract: Περιγράφονται ενώσεις διυποκατεστημένου οκταϋδροπυρρολο[3,4-c]πυρρολίου, που είναι χρήσιμες ως ρυθμιστές υποδοχέα ορεξίνης. Τέτοιες ενώσεις μπορεί να είναι χρήσιμες σε φαρμακευτικές συνθέσεις και μεθόδους για τη θεραπεία καταστάσεων ασθένειας, διαταραχών και καταστάσεων που προκαλούνται με δραστικότητα ορεξίνης, όπως αϋπνίας.
Patent CY-1117846-T1 (CY)
Title: 1-(3,3-ΔΙΜΕΘΥΛΟΒΟΥΤΥΛΟ)-3-(2-ΦΘΟΡΟ-4-ΜΕΘΥΛΟ-5-(7-ΜΕΘΥΛΟ-2-(ΜΕΘΥΛΑΜΙΝΟ)ΠΥΡΙΔΟ-[2,3-d]ΠΥΡΙΜΙΔΙΝ-6-ΥΛΟ)ΦΑΙΝΥΛ)ΟΥΡΙΑ ΩΣ ΑΝΑΣΤΟΛΕΑΣ ΚΙΝΑΣΗΣ RAF ΣΤΗΝ ΑΓΩΓΗ ΕΝΑΝΤΙ ΤΟΥ ΚΑΡΚΙΝΟΥ
Inventor: ALLGEIER MATTHEW CARL
IPC: C07D471/04
Filed: 2016-07-22
Abstract: Η παρούσα εφεύρεση παρέχει την ένωση 1-(3,3-διμεθυλοβουτυλο)-3-(2-φθορο-4-μεθυλο-5-(7-μεθυλο-2-(μεθυλαμινο)πυριδο[2,3-d]πυριμιδιν-6-υλο)-φαινυλ)ουρία ή ένα φαρμακευτικά αποδεκτό άλας αυτής, που αναστέλλει τη Raf και, για αυτό, μπορεί να ενέχει χρησιμότητα στην αγωγή έναντι του καρκίνου.
Patent CY-1120349-T1 (CY)
Title: Συστηματα και μεθοδοι για την αγωγη του προστατικου ιστου
Inventor: HOEY MICHAEL
IPC: A61B18/04
Filed: 2018-06-18
Abstract: Παρέχεται ένα σύστημα θεραπείας του προστάτη το οποίο μπορεί να περιλαμβάνει οποιοδήποτε από έναν αριθμό χαρακτηριστικών. Ένα χαρακτηριστικό του συστήματος θεραπείας του προστάτη είναι ότι μπορεί να προσπελάσει διουρηθρικά έναν προστατικό λοβό. Ένα άλλο χαρακτηριστικό του συστήματος θεραπείας του προστάτη είναι ότι μπορεί να χορηγήσει συμπυκνώσιμο ατμό εντός του προστάτη για να εκτμήσει τον προστατικό ιστό. Καλύπτονται επίσης μέθοδοι σχετιζόμενες με τη χρήση του συστήματος θεραπείας του προστάτη.
Patent CY-1123395-T1 (CY)
Title: Ενωσεις καρβοξαμιδιων ινδολης χρησιμες ως αναστολεις κινασων
Inventor: AHMAD SALEEM
IPC: C07D403/12
Filed: 2020-08-11
Abstract: Αποκαλύπτονται ενώσεις του Χημικού Τύπου (Ι): ή ένα άλας εξ αυτών, όπου: το Χ είναι CR4 ή Ν· τα R1, R2, R3, R4, και Α καθορίζονται εις το παρόν. Επίσης αποκαλύπτονται και μέθοδοι χρήσης τέτοιων ενώσεων ως αναστολείς της κινάσης τυροσίνης του Bruton (Btk), και φαρμακευτικές συνθέσεις που περιλαμβάνουν τέτοιες ενώσεις. Αυτές οι ενώσεις είναι χρήσιμες σε αγωγή, πρόληψη, ή επιβράδυνση της προόδου των παθήσεων ή διαταραχών σε μια ποικιλία θεραπευτικών περιοχών, όπως είναι οι αυτοάνοσες παθήσεις και οι αγγειακή πάθηση.
Patent HR-P20100495-T1 (HR)
Title: A media system and method
Inventor: CEBOLLA JESUS HORMIGO
IPC: A63F13/00
Filed: 2010-09-06
Abstract: An interactive media system configured to present a substantially real-time simulation of an actual live event involving a moveable object in an arena, the system comprising: a tag attachable to a moveable object involved in an actual live event in an arena; one or more base stations located relative to the arena and operable to receive a signal from the tag; a location platform configured to determine the location of the tag in the arena based on the signal received from the tag by the or each base station, and to output location data representing a location of the tag in the arena; a virtual world environment unit to simulate the actual live event including the arena, the object, and movement of the object in the arena using the location data for the tag; and an access interface in communication with the virtual world environment unit, the access interface being arranged to provide a user with access to the simulated arena and to permit the user to observe the simulated event in substantially real-time.
Patent HR-P20110087-T1 (HR)
Title: Device at cardeck for vehicles on ships
Inventor: SALEN HANS
IPC: B63B3/48
Filed: 2011-02-03
Abstract: An upper deck section (4) can be packed tightly against and supported by a lower deck section (5) underneath to form a single deck unit (7).  The deck (2) comprises a number of raisable deck sections which can be moved up and down and fixed into position using locking devices (6).
Patent HR-P20110161-T1 (HR)
Inventor: BOHLMANN ROLF
IPC: C07J53/00
Filed: 2011-03-04
Abstract: 18-metil-15?,16?-metilen-19-nor-20-spiroks-4-en-3-oni opće formule Inaznačeni time daZ predstavlja atom kisika, dva atoma vodika, skupinu =NOR ili =NNHSO2R, pri čemu je R atom vodika ili alkilna skupina ravnog ili razgranatog lanca sa 1 do 4 odnosno 3 do 4 atoma ugljika, R4 predstavlja atom vodika, atom halogena ili trifluormetilnu skupinu, i R6 i/ili R7 može biti u α ili ? položaju i R6 i R7 su nezavisno jedan od drugoga atom vodika ili alkilna skupina sa ravnim ili razgranatim lancem koja ima 1 do 4 odnosno 3 do 4 atoma ugljika ili alkenilna skupina sa ravnim ili razgranatim lancem koja ima 2 do 4 odnosno 3 do 4 atoma ugljika ili zasićena cikloalkilna skupina koja ima 3 do 5 atoma ugljika ili zajedno su metilenska skupina ili dvostruka veza. Patent sadrži još 12 patentnih zahtjeva.
Patent SI-1380301-T1 (SI)
Title: Pharmaceutical combination of ethinylestradiol and dropirenone for use as a contraceptive
Inventor: HEIL WOLFGANG
IPC: A61K31/00
Filed: 2000-08-31
Abstract: The present invention relates to a multiple-phase pharmaceutical preparation consisting of a number of separately packaged and individually removable daily dosage units placed in a packaging unit and intended for oral administration for a period of at least 21 consecutive days, wherein said daily dosage unit comprises a natural estrogen, such as estradiol in an amount of from 0.5 mg to 4 mg, and 2 to 4 mg of drospirenone, and wherein at least 70% of said drospirenone is dissolved from said dosage unit within 30 minutes, as determined by USP XXIII Paddle Method II using water at 37°C as the dissolution media and 50 rpm as the stirring rate.
Patent SI-1303527-T1 (SI)
Title: Matrix metalloproteinase inhibitors
Inventor: SOERENSEN MORTEN DAHL
IPC: A61P35/00
Filed: 2001-07-03
Abstract: A compound of the general formula Iwherein Y is O or S;n is 1, 2, 3 or 4;X represents hydroxamic acid, carboxylic acid, phosphonic acid, acetylthiomethyl group or a mercaptomethyl group;R1 iswherein E, when present represents, a bond or optionally substituted methylene or ethylene;s and t are independently 0, 1, 2 or 3;A and A' independently represent a bond, or a saturated or unsaturated, optionally substituted cyclic or heterocyclic hydrocarbon di- or triradical;Z represents a bond, O, S, C(O), C(O)NR7, NR7C(O) or NR7, wherein R7 is hydrogen, hydroxy, branched or straight, saturated or unsaturated, optionally substituted hydrocarbon radical;R5 represents a bond, alkane or alkene diradical, one or more ether diradicals (R-O-R') or amine diradicals (R-N-R'), wherein R and R' independently represent alkane or alkene diradicals with a C-content from 0 to 3;R6 represents hydrogen, hydroxy, halogen, cyano, nitro, branched or straight, saturated or unsaturated, optionally substituted hydrocarbon radical, unsaturated optionally substituted cyclic or heterocyclic hydrocarbon radical, NR8R9, C(O)NR8R9, C(O)R8, CO(O)R8, S(O)2R9, wherein each R8 and R9 independently represent hydrogen, halogen, a branched or straight, saturated or unsaturated, optionally substituted hydrocarbon radical;R2 represents hydrogen, (C1-8)alkyl, (C2-6)alkenyl, (C3-8)cycloalkyl, aryl(C0-6)alkyl or heteroaryl(C0-6)alkyl;provided that if A, A', Z and R5 are all bonds, and s and t are both 0 (zero), then R6 is different from hydrogen;or a salt, hydrate or solvate thereof.The compounds are valuable for human and veterinary therapy.
Patent SI-1548451-T1 (SI)
Title: System for the remote reading and control of electric energy consumption
Inventor: ROGAI SERGIO
IPC: G01R1/00
Filed: 2002-12-20
Abstract: A system for the remote acquisition of data and for the remote control of electricity meters comprises a central server AMM in bi-directional communication with a plurality of concentrators. To each concentrator, a set of electricity meters is connected, such that bi-directional communication between each meter and its associated concentrator is possible. The intelligence of the system is distributed between the central server, the concentrators and the electricity meters. To this end, each meter comprises at least a first processor, a first data memory and a first program memory for bi-directional communication with the associated concentrator. The first data memory serves to at least temporarily store and/or transmit the data which have already undergone a first processing by the first processor. Each of the concentrators comprises a second processor, a second program memory and a second data memory as well as means for a bi-directional communication with a central server. The second data memory serves to temporarily store and/or transmit the data processed by the second processor. The concentrators reproduce a virtual image of electricity meters downstream of the respective concentrator for the transactions, exchange of data or for receiving controls and/or programs from the central server. <IMAGE>
Patent SI-1502996-T1 (SI)
Title: Grid plate
Inventor: LANDGRAF RAINER
IPC: E01C9/00
Filed: 2003-07-31
Abstract: Each nodal point (1) has a small diameter vertical tube sealed at the bottom by a baseplate (8). Four vertical walls (5) come together at each node. Each wall has two arcuate portions meeting at an angle midway between a pair of nodes, and the walls define rosette shapes (2) and star shapes (3). There are flanges (17.1) projecting into the star shapes and narrow flanges (17.2) projecting into the rosette shapes. There are reinforcing fillets (16) at the meeting of the arcuate wall portions and (18) at the nodal points.
Patent SI-1680462-T1 (SI)
Title: Method for producing an antistatically coated molded body
Inventor: HASSKERL THOMAS
IPC: C08J7/044
Filed: 2004-08-06
Abstract: A process is described for producing mouldings from plastics by coating a moulding on one or more sides with a lacquer system, the lacquer system being composed of a binder or a binder mixture, optionally a solvent or solvent mixture, optionally other additives usual in lacquer systems and a thickener, and use can be made here of polymeric thickeners at from 0 to 20% content and oligomeric thickeners at from 0 to 40% content, in each case based on dry film (components a, c, d, e), from 5 to 500 parts by weight, based on a), of an electrically conductive metal oxide powder with a median primary particle size of from 1 to 80 nm and a percentage degree of aggregation of from 0.01 to 99%, from 5 to 500 parts by weight, based on a), of inert nanoparticles coated in a manner known per se and the lacquer cured.
Patent SI-1564148-T1 (SI)
Title: Apparatus for creating a vacuum in containers for preserving vacuum-packed products
Inventor: ABATE LUIGI
IPC: B65B31/00
Filed: 2005-02-03
Abstract: This invention concerns an apparatus to form a vacuum in containers for preserving vacuum-packed products, which is made up of body (11) having a housing (26) on the rear of its closing lever (13) designed to contain a rolled tubular element (27) for the formation of bags and closed by a cover (28), independent of said lever (13) and turning on its own axis, and an electromagnetic single phase safety transformer (19) to feed at least some electric parts the length size of which is greater than the height and width dimensions and is equipped with terminals to be electrically connected to other devices.
Patent SI-2138289-T1 (SI)
Title: Method for producing a longitudinally slotted grid element
Inventor: SCHWARZ RUDOLF
IPC: A01K1/015
Filed: 2008-06-23
Abstract: The method involves loading a rubber coating (46) with pressure by a pressurizing device e.g. cylinder (60), during vibration of a casting mold (36) using a vibrator (32), till an upper side of the coating is found to the height of a surface of the mold. A concrete (44) is brought to the height of an upper side of the coating, at sections of transverse and longitudinal beams that are not covered by the coating. The mold is rotated so that the upper side of the coating is represented in a downward manner. A grid floor element is removed from the mold in a downward manner. An independent claim is also included for a system for producing a grid floor element.
Patent SI-2522799-T1 (SI)
Title: Self-closing device for sliding doors
Inventor: TARREGA LLORET MIGUEL ANGEL
IPC: E05F5/00
Filed: 2012-04-27
Abstract: Self-closing device for sliding doors of the type comprising at least one sliding leaf (2) which is hung from an upper profile (3). Said device (1) comprises a drive belt (10) configured to be joined to the sliding leaf (2); a closing pulley (20), provided with elastic means (30), which is arranged on a first rotation axis (4) integral to the upper profile (3) and which engages with a first end (11) of the drive belt (10); and a brake pulley (40), provided with stopping means (50), which is arranged on a second rotation axis (5) integral to the upper profile (3) and which engages with a second end (12) of the drive belt (10) opposite to the first end (11), thus the rotation movement of both pulleys (20, 40) being connected by the drive belt (10).
Patent TR-200606995-T1 (TR)
Title: Etkileşimli mobil on-line görsel bilgilendirme ve eğlendirme hizmeti
Inventor: SUNER OEZGUER
IPC: H04N7/173
Filed: 2005-02-07
Abstract: Bu buluş, mobil iletişim servis sağlayıcısı üzerinden, servis veya içerik sağlayıcısı tarafından sunulan, başlığı önceden belirlenmiş canlı veya önceden kayıtlı, sesli veya sessiz, hareketli görüntüler içeren bir yayına, kullanıcının kendi mobil iletişim aracı, örneğin mobil telefonu, aracılığı ile ulaşarak bu görüntüler arasından seçim yapmak, ve bu hareketli görüntü ve/veya yayındaki kimse ile servis veya içerik sağlayıcısının belirlediği bir protokol çerçevesinde veya kendi tercihine bağlı olarak kendi görseli ile ve/veya yazılı ve/veya sözlü olarak iletişim kurmak yoluyla bilgi edinmesi, eğitim alması, danışması, eğlenmesi, ticaret/alışveriş yapması için hazırlanmış bir etkileşimli, mobil, on-line, görsel, bilgilendirme ve eğlendirme hizmeti (Interactive Mobile On-line Visual Information and Entertainment Service: IN-MOVIES) sağlanması için kullanılan bir yöntem ile ilgilidir.
Patent DE-3486135-T2 (DE)
Inventor: HADZOGLOU JAMES
IPC: H01Q1/32
Filed: 1984-09-21
Granted: 1993-09-16
Abstract: A mobile antenna system for use at frequencies in and above the 800 MHz band having a collinear radiator (10) mounted on one surface of a dielectric (14) such as the window of a vehicle and a tunable coupling circuit disposed internally of a conducted housing (22) mounted on the opposite surface of the dielectric (14) which acts as a counterpoise for coupling RF energy between the radiator (10) and a transmission line (42) connected to a suitable transceiver
Patent DE-3586402-T2 (DE)
Inventor: KUO GEORGE
IPC: C12Q1/68
Filed: 1985-01-11
Granted: 1993-01-07
Abstract: (1) Protein compsn. (free from other proteins) showing a biological activity of Factor VIIIC and being a complex of an 80 kd and 77 kd protein calcium bridged with a 92.5 kd protein is new. (2) Human protein compsn. comprising 1 or 2 polypeptides of 67-80 kd and having an amino acid sequence of formula (I) in the N-terminal half of the polypeptide and having a biological activity of Factor VIIIC is new. (3) Human protein compsn. comprising a polypeptide of 92.5 kd and having an amino acid sequence of formula (II) in the N-terminal half of the polypeptide and having a biological activity of Factor VIIIC. (4) Monoclonal antibody prepd. with a protein compsn. as defined in paragraphs (1)-(3) is new. (5) Detection of a polynucleotide sequence encoding for at least part of Factor VIIIC comprises hybridising it, in single-stranded form, with a probe (III) and then isolating polynucleotide duplexing with the probe.
Patent DE-3586520-T2 (DE)
Inventor: ROIZMAN BERNARD
IPC: C12P19/34
Filed: 1985-05-30
Granted: 1993-01-07
Abstract: A foreign gene is inserted into a viral genome under the control of promoter-regulatory regions of the genome, thus providing a vector for the expression of the foreign gene. DNA constructs, plasmid vectors containing the constructs useful for expression of the foreign gene, recombinant viruses produced with the vector, and associated methods are disclosed.
Patent DE-3687236-T2 (DE)
Inventor: RIEBEL ALEXANDER
IPC: C12Q1/00
Filed: 1986-03-05
Granted: 1993-04-15
Abstract: The invention relates to proteins bound to polyamides or cellulose hydrate and to a process for the preparation of these carrier-bound proteins. The carrier-bound proteins can, for example, be used for the preparation of biocatalysts, chromatography materials or test strips. For the preparation of test strips the carriers are particularly suitable in the form of films or membranes.